title: Alpha-1 acid glycoprotein is an immunosuppressive factor found in ascites from ovaria carcinoma.
abstract: BACKGROUND
  Although the ascites of patients with ovarian carcinoma has been reported to contain immunosuppressive factors, the identity and source of this activity has not been fully elucidated. The objective of this study was to describe the purification of a single immunosuppressive protein, alpha-1 acid glycoprotein, from ovarian carcinoma ascites, identify its site of production, and describe a possible mechanism by which it inhibits lymphocytes.
  
  
  METHODS
  Ascites from proteins from five patients with epithelial ovarian carcinoma first were differentially precipitated by size with different concentrations of polyethylene glycol and then separated on the basis of isoelectric focusing. The protein factions then were placed in a lymphocyte proliferation assay to determine immunosuppressive activity. Western blot analysis was used to identify alpha-1 acid glycoprotein as an immunosuppressive protein in ascites. Total RNA was extracted from ovarian and hepatic cell lines as well as primary and recurrent ovarian tumor samples. Reverse-transcriptase polymerase chain reaction then was utilized to identify the site of production of this protein. Purified alpha-1 acid glycoprotein was placed in lymphocyte culture and its effects on lymphocyte interleukin-2 (IL-2) production were measured by enzyme-linked immunoadsorbent assay.
  
  
  RESULTS
  Addition of purified alpha-1 acid glycoprotein to the lymphocyte assay resulted in a 60% decrease in lymphocyte proliferation (P < 0.05). Alpha-1 acid glycoprotein transcript was not identified in ovarian tumor cells. The addition of purified alpha-1 acid glycoprotein to the lymphocyte culture resulted in a 65% decrease in IL-2 secretion into the media (P < 0.05).
  
  
  CONCLUSIONS
  Alpha-1 acid glycoprotein is an immunosuppressive protein purified from ovarian carcinoma ascites. It is not expressed primarily by ovarian carcinoma cells. It appears to inhibit IL-2 secretion by lymphocytes.
authors.affiliation: Department of Obstetrics and Gynecology, Walter Reed Army Medical Center, Washington, D.C. 20307-5001, USA.
authors.forename: S A
authors.initials: SA
authors.lastname: Elg
authors.forename: A R
authors.initials: AR
authors.lastname: Mayer
authors.forename: L F
authors.initials: LF
authors.lastname: Carson
authors.forename: L B
authors.initials: LB
authors.lastname: Twiggs
authors.forename: R B
authors.initials: RB
authors.lastname: Hill
authors.forename: S
authors.initials: S
authors.lastname: Ramakrishnan
mesh_terms: D001201:Ascites / Q000378:metabolism; D004591:Electrophoresis, Polyacrylamide Gel; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000302:isolation & purification*; D008213:Lymphocyte Activation / Q000187:drug effects / Q000276:immunology; D008214:Lymphocytes / Q000276:immunology; D009363:Neoplasm Proteins / Q000096:biosynthesis / Q000276:immunology / Q000302:isolation & purification*; D009961:Orosomucoid / Q000096:biosynthesis / Q000276:immunology / Q000302:isolation & purification*; D010051:Ovarian Neoplasms / Q000737:chemistry* / Q000276:immunology / Q000378:metabolism; D014407:Tumor Cells, Cultured
chemical_list: D007166:Immunosuppressive Agents; D009363:Neoplasm Proteins; D009961:Orosomucoid